ENPENTROPY NEURODYNAMICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Aug 2026, 18:20 | TRP 8803 manufacturing secured for Phase 2/3 advancement | Company Update | MS | 11001 | |
| 7 Aug 2026, 23:47 | Change of Director's Interest Notice - HJ | Director Interests | — | 02009 | |
| 7 Aug 2026, 19:49 | Cleansing Notice | Securities Administration | — | 06018 | |
| 7 Aug 2026, 19:44 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 7 Aug 2026, 18:53 | BioShares 2026 Investor Presentation Deck | Presentations | — | 03026 | |
| 4 Aug 2026, 19:10 | 72-Patient Trial Fast-Tracks TRP-8803 Commercialisation | Company Update | MS | 09014, 11001 | |
| 31 July 2026, 19:17 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 27 July 2026, 19:12 | Techknow Invest Roadshow presentation | Presentations | — | 03026 | |
| 25 July 2026, 00:06 | Appointment of Joint Company Secretary | Company Administration | — | 12007 | |
| 22 July 2026, 18:26 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 20 July 2026, 18:35 | South Africa Grants ENP Broad Fibromyalgia Patent to 2043 | Company Update | MS | 11001 | |
| 10 July 2026, 19:07 | Additional Australian patent granted | Company Update | — | 11001 | |
| 9 July 2026, 21:13 | Investor Presentation | Presentations | — | 03026 | |
| 7 July 2026, 19:37 | 100% Clinical improvement, 50% Remission in BED study | Company Update | MS | 09014, 11001, 14014 | |
| 3 July 2026, 19:09 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 26 June 2026, 22:29 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 26 June 2026, 22:25 | Top 20 Option Holders & Distribution Schedule | Securities Administration | — | 03002, 06009 | |
| 26 June 2026, 03:27 | Proposed issue of securities - ENP | Securities Administration | — | 06013 | |
| 26 June 2026, 03:12 | Short Form Prospectus | Securities Administration | — | 06009, 06010 | |
| 15 June 2026, 19:55 | DSMB Clears TRP 8803 to Advance to Cohort 2 | Company Update | MS | 11001 | |
| 2 June 2026, 18:56 | Entropy completes Cohort 1 dosing in BED trial | Company Update | MS | 11001 | |
| 29 May 2026, 21:07 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 22 May 2026, 23:32 | Release of Securities from Escrow | Securities Administration | — | 06009 | |
| 15 May 2026, 23:46 | Notification of cessation of securities - ENP | Other | — | 06027 | |
| 14 May 2026, 19:23 | Change of Director's Interest Notice - JC | Director Interests | — | 02009 | |
| 11 May 2026, 19:44 | Australian Microcap Investment Conference presentation | Presentations | — | 03026 | |
| 5 May 2026, 19:38 | Entropy files new US patent for IBS program | Company Update | MS | 11001, 14014 | |
| 4 May 2026, 19:08 | TRP 8802 delivers 75% breakthrough response in IBS | Company Update | MS | 11001, 14014 | |
| 28 Apr 2026, 19:29 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 21 Apr 2026, 00:53 | Change of Director's Interest Notice - CN, DT, JC & HJ | Director Interests | — | 02009 | |
| 18 Apr 2026, 02:45 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 Apr 2026, 02:40 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 14 Apr 2026, 20:49 | Cleansing Notice | Securities Administration | — | 06018 | |
| 14 Apr 2026, 20:47 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 14 Apr 2026, 19:29 | TRP-8803 delivers repeatable, high-intensity effect | Company Update | MS | 11001 | |
| 31 Mar 2026, 01:18 | Notification regarding unquoted securities - ENP | Other | — | 06021 | |
| 20 Mar 2026, 03:21 | Results of EGM | Meetings & Governance | — | 08003 | |
| 14 Mar 2026, 01:21 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 11 Mar 2026, 00:04 | Change of Director's Interest Notice - JC | Director Interests | — | 02009 | |
| 10 Mar 2026, 23:09 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 5 Mar 2026, 20:45 | FY25 R&D Tax Incentive received | Periodic Reports | MS | 03014, 12008 | |
| 3 Mar 2026, 19:58 | Cohort 1 enrolment achieved for TRP-8803 BED Trial | Company Update | MS | 11001 | |
| 3 Mar 2026, 00:21 | Application for quotation of securities - ENP | Other | — | 06020 | |
| 27 Feb 2026, 20:13 | Appendix 4D and Half Year Report for period 31 Dec 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 17 Feb 2026, 02:40 | Update to Appendix 3B | Meetings & Governance | — | 06013, 08006 | |
| 12 Feb 2026, 19:32 | Australian Patent Secures TRP 8803 Platform to 2042 | Company Update | MS | 11001 | |
| 9 Feb 2026, 21:20 | 2026 EGM Letter of Access, Notice of Meeting and Proxy | Meetings & Governance | — | 08002, 08004, 16002 | |
| 7 Feb 2026, 01:57 | Change of Director's Interest Notice - JC | Director Interests | — | 02009 | |
| 4 Feb 2026, 20:50 | Change of Director's Interest Notice - JC | Director Interests | — | 02009 | |
| 3 Feb 2026, 03:21 | Application for quotation of securities - ENP | Other | — | 06020 |
1–50 of 64
1 / 2